Article
LAMAs in Real-Life Asthma Management - The 2023 EU-LAMA Survey Results
2025-06-25
Abstract excerpt
<h4>Background: </h4> Triple therapy (long-acting muscarinic antagonists (LAMAs), long-acting beta agonists (LABAs), inhaled corticosteroids (ICSs) is a recommended treatment for moderate-to-severe asthma at GINA steps 4 and 5. However, little is known about the acceptance and use of triple therapy in everyday practice. The EU-LAMA Survey assessed specialists’ knowledge and views on triple therapy in daily practic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b62e6303-5082-5301-a730-24d74279524c
- DOI
- 10.20944/preprints202506.1958.v1
